Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Castellino SM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-11 z 11
    Tytuł:
    Impact of insurance type on survivor-focused and general preventive health care utilization in adult survivors of childhood cancer: the Childhood Cancer Survivor Study (CCSS).
    Autorzy:
    Casillas J
    Castellino SM
    Hudson MM
    Mertens AC
    Lima IS
    Liu Q
    Zeltzer LK
    Yasui Y
    Robison LL
    Oeffinger KC
    Casillas, Jacqueline
    Castellino, Sharon M
    Hudson, Melissa M
    Mertens, Ann C
    Lima, Isac S F
    Liu, Qi
    Zeltzer, Lonnie K
    Yasui, Yutaka
    Robison, Leslie L
    Oeffinger, Kevin C
    Pokaż więcej
    Źródło:
    Cancer (0008543X); 5/1/2011, Vol. 117 Issue 9, p1966-1975, 10p
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Utilization of cardiac tests in anthracycline-treated cancer survivors differs between young adults and children: A claims-based analysis.
    Autorzy:
    Ji X; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Hu X; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
    Lipscomb J; Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
    Chow EJ; University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
    Mertens AC; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Castellino SM; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 22056-22061. Date of Electronic Publication: 2023 Dec 09.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
    MeSH Terms:
    Cancer Survivors*
    Neoplasms*/drug therapy
    Heart Failure*
    Child ; Adolescent ; Humans ; Young Adult ; Anthracyclines/adverse effects ; Antibiotics, Antineoplastic/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org.
    Autorzy:
    Taylor ZL; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
    Miller TP; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Poweleit EA; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Division of Research in Patient Services, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Biomedical Informatics, University of Cincinnati, Cincinnati, Ohio, USA.; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
    DeGroote NP; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Pommert L; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
    Awoniyi O; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Board SG; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Division of Research in Patient Services, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
    Ugboh N; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Joshi V; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Ambrosino N; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
    Chavana A; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
    Bernhardt MB; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer Center, Houston, Texas, USA.
    Schafer ES; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer Center, Houston, Texas, USA.
    O'Brien MM; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
    Castellino SM; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
    Ramsey LB; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Research in Patient Services, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
    Pokaż więcej
    Źródło:
    Clinical and translational science [Clin Transl Sci] 2023 Nov; Vol. 16 (11), pp. 2130-2143. Date of Electronic Publication: 2023 Aug 03.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Methotrexate*
    Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
    Adolescent ; Young Adult ; Child ; Humans ; Antimetabolites, Antineoplastic/pharmacokinetics ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
    Autorzy:
    Mumme HL; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Biomedical Informatics, Emory University, Atlanta, GA, USA.
    Raikar SS; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University, Atlanta, GA, USA.
    Bhasin SS; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University, Atlanta, GA, USA.
    Thomas BE; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University, Atlanta, GA, USA.
    Lawrence T; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.
    Weinzierl EP; Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA.
    Pang Y; Department: Pediatrics - Hematology/Oncology, Stanford University, Stanford, CA, USA.
    DeRyckere D; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University, Atlanta, GA, USA.
    Gawad C; Department: Pediatrics - Hematology/Oncology, Stanford University, Stanford, CA, USA.
    Wechsler DS; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University, Atlanta, GA, USA.
    Porter CC; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University, Atlanta, GA, USA.
    Castellino SM; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University, Atlanta, GA, USA.
    Graham DK; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University, Atlanta, GA, USA.
    Bhasin M; Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA. .; Department of Biomedical Informatics, Emory University, Atlanta, GA, USA. .; Department of Pediatrics, Emory University, Atlanta, GA, USA. .
    Pokaż więcej
    Źródło:
    Genome medicine [Genome Med] 2023 Oct 16; Vol. 15 (1), pp. 83. Date of Electronic Publication: 2023 Oct 16.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
    Leukemia, Myeloid, Acute*/genetics
    Leukemia, Myeloid, Acute*/pathology
    Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
    Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
    Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
    Adult ; Humans ; Child ; Acute Disease ; Phenotype ; Sequence Analysis, RNA ; Tumor Microenvironment
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.
    Autorzy:
    Bhasin SS; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA. .; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. .
    Thomas BE; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
    Summers RJ; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
    Sarkar D; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA.
    Mumme H; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA.
    Pilcher W; Wallace H Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
    Emam M; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
    Raikar SS; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
    Park SI; Department of Pathology, Children's Healthcare of Atlanta, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
    Castellino SM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
    Graham DK; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
    Bhasin MK; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA.; Wallace H Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
    DeRyckere D; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2023 Aug 02; Vol. 13 (1), pp. 12556. Date of Electronic Publication: 2023 Aug 02.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
    Humans ; Child ; Transcriptome ; Bone Marrow ; Recurrence ; Bone Marrow Cells ; Prognosis ; Tumor Microenvironment/genetics ; SOXC Transcription Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia.
    Autorzy:
    West ZE; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
    Castellino SM; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.
    Monroe C; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.
    Thomas AS; Department of Pediatrics, Biostatistics Core, Emory University School of Medicine, Atlanta, GA, USA.
    McCracken C; Department of Pediatrics, Biostatistics Core, Emory University School of Medicine, Atlanta, GA, USA.
    Miller TP; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.
    Pokaż więcej
    Źródło:
    Leukemia & lymphoma [Leuk Lymphoma] 2021 Apr; Vol. 62 (4), pp. 899-908. Date of Electronic Publication: 2020 Dec 01.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
    Precursor Cell Lymphoblastic Leukemia-Lymphoma*/epidemiology
    Child ; Cohort Studies ; Humans ; Induction Chemotherapy/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Evaluating palliative opportunities in pediatric patients with leukemia and lymphoma.
    Autorzy:
    Labudde EJ; Emory University School of Medicine, Atlanta, GA, USA.
    DeGroote NP; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, GA, USA.
    Smith S; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, GA, USA.
    Ebelhar J; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Division of Pediatric Hematology/Oncology, Emory University, Atlanta, GA, USA.
    Allen KE; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, GA, USA.
    Castellino SM; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Division of Pediatric Hematology/Oncology, Emory University, Atlanta, GA, USA.
    Wasilewski-Masker K; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Division of Pediatric Hematology/Oncology, Emory University, Atlanta, GA, USA.
    Brock KE; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, GA, USA.; Department of Pediatrics, Division of Pediatric Hematology/Oncology, Emory University, Atlanta, GA, USA.; Department of Pediatrics, Division of Pediatric Palliative Care, Emory University, Atlanta, GA, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2021 Apr; Vol. 10 (8), pp. 2714-2722. Date of Electronic Publication: 2021 Mar 22.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Leukemia/*mortality
    Leukemia/*therapy
    Lymphoma/*mortality
    Lymphoma/*therapy
    Palliative Care/*methods
    Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Leukemia/pathology ; Lymphoma/pathology ; Male ; Retrospective Studies ; Terminal Care/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells.
    Autorzy:
    Liu R; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, Atlanta, GA, 30322, USA.; Department of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, 410013, Hunan, China.
    Li D; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, Atlanta, GA, 30322, USA.
    Sun F; School of Chemistry and Biochemistry and the Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
    Rampoldi A; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, Atlanta, GA, 30322, USA.
    Maxwell JT; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, Atlanta, GA, 30322, USA.
    Wu R; School of Chemistry and Biochemistry and the Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
    Fischbach P; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, Atlanta, GA, 30322, USA.
    Castellino SM; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, Atlanta, GA, 30322, USA.
    Du Y; Emory Chemical Biology Discovery Center and the Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, 30322, USA.
    Fu H; Emory Chemical Biology Discovery Center and the Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, 30322, USA.
    Mandawat A; Department of Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Cardio-Oncology Program, Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA.
    Xu C; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. .; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30322, USA. .
    Pokaż więcej
    Źródło:
    Stem cell research & therapy [Stem Cell Res Ther] 2020 Nov 05; Vol. 11 (1), pp. 470. Date of Electronic Publication: 2020 Nov 05.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Induced Pluripotent Stem Cells*
    Cardiotoxicity/genetics ; Cells, Cultured ; Humans ; Melphalan/metabolism ; Melphalan/toxicity ; Myocytes, Cardiac/metabolism ; Oxidative Stress ; Proteomics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.
    Autorzy:
    Witkowski L; 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [3].
    Carrot-Zhang J; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [3].
    Albrecht S; Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
    Fahiminiya S; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
    Hamel N; 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
    Tomiak E; Department of Genetics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
    Grynspan D; Department of Pathology and Laboratory Medicine, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
    Saloustros E; Hereditary Cancer Clinic, Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
    Nadaf J; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
    Rivera B; 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
    Gilpin C; Department of Genetics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
    Castellsagué E; 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
    Silva-Smith R; 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
    Plourde F; 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
    Wu M; 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
    Saskin A; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
    Arseneault M; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
    Karabakhtsian RG; 1] Department of Pathology and Laboratory Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA. [2].
    Reilly EA; Department of Pathology and Laboratory Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
    Ueland FR; Department of Pathology and Laboratory Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
    Margiolaki A; Hereditary Cancer Clinic, Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
    Pavlakis K; Pathology Department, National and Kapodistrian University of Athens, Athens, Greece.
    Castellino SM; Department of Pediatrics, Hematology/Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
    Lamovec J; Department of Pathology, Institute of Oncology, Ljubljana, Slovenia.
    Mackay HJ; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
    Roth LM; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Ulbright TM; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Bender TA; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Georgoulias V; Hereditary Cancer Clinic, Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
    Longy M; Institut Bergonié, Unité d'Oncogénétique, Bordeaux, France.
    Berchuck A; Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina, USA.
    Tischkowitz M; Department of Medical Genetics, University of Cambridge, Cambridge, UK.
    Nagel I; Institute of Human Genetics, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
    Siebert R; Institute of Human Genetics, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
    Stewart CJ; School for Women's and Infants' Health, University of Western Australia, Perth, Western Australia, Australia.
    Arseneau J; Department of Pathology, Royal Victoria Hospital, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
    McCluggage WG; Department of Pathology, Royal Group of Hospitals Trust, Belfast, UK.
    Clarke BA; Department of Pathology Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
    Riazalhosseini Y; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
    Hasselblatt M; Institute of Neuropathology, University Hospital-Münster, Münster, Germany.
    Majewski J; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
    Foulkes WD; 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. [3] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [4] Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
    Pokaż więcej
    Źródło:
    Nature genetics [Nat Genet] 2014 May; Vol. 46 (5), pp. 438-43. Date of Electronic Publication: 2014 Mar 23.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Carcinoma, Small Cell/*genetics
    DNA Helicases/*genetics
    Mutation/*genetics
    Nuclear Proteins/*genetics
    Ovarian Neoplasms/*genetics
    Transcription Factors/*genetics
    Base Sequence ; Cell Line, Tumor ; Exome/genetics ; Female ; Gene Components ; Humans ; Immunoblotting ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; Molecular Sequence Data ; Sequence Analysis, DNA
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-11 z 11

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies